@article{ac259d735c27498bb4ae2f1392a3e158,
title = "Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy",
keywords = "Adalimumab, Aged, Anti-Inflammatory Agents/adverse effects, Antibodies, Monoclonal, Humanized/adverse effects, Cholestasis/chemically induced, Female, Histoplasmosis/complications, Humans, Immunosuppression, Immunosuppressive Agents/adverse effects, Severity of Illness Index",
author = "\{van Welzen\}, \{Berend J\} and \{van Erpecum\}, \{Karel J\} and Haas, \{Pieter-Jan A\} and \{ten Kate\}, \{Fiebo J\} and Tania Mudrikova",
year = "2013",
month = sep,
doi = "10.1016/j.clinre.2013.03.008",
language = "English",
volume = "37",
pages = "e105--e107",
journal = "Clinics and Research in Hepatology and Gastroenterology",
issn = "2210-7401",
publisher = "Elsevier Masson",
number = "4",
}